Sunday, May 4, 2025
5/4/2025
Phosphorylation of α/β Tubulin is a 'Toggle Switch' in Human Breast Cancer - “Phosphorylation of α/β-Tubulin is a ‘Toggle Switch’ in Human Breast Cancer The α/β-tubulin heterodimer is the building block of microtubules (MTs) which comprise an essential component of the cell cytoskeleton. MTs undergo growth/shrinkage episodes as dictated by whether GTP is bound to β-tubulin (β:GTP) (assembly) or is hydrolyzed to GDP (disassembly). Protein kinase C (PKC) is a key signaling enzyme that controls these MT events in human breast cells. In this regard, PKC phosphorylates α-tubulin at Ser165 (α:Ser165) resulting in persistent MT elongation and breast cell motility while proliferation is suppressed. Molecular dynamics simulations and validating experiments showed that phosphorylation of α:Ser165 misaligns the catalytic residue Glu254 in α-tubulin (α:Glu254) with its substrate β:GTP, leading to diminished hydrolysis of β:GTP, thereby increasing GTP caps and causing persistent MT elongation. β-tubulin undergoes phosphorylation at Ser172 by cyclin-dependent kinase-1 (cdk-1) which promotes proliferation, a process that requires α/β-tubulin to form spindle fibers during cell division. Thus, PKC and cdk1 produce opposing effects on microtubule structure, GTP binding/hydrolysis, and cell proliferation. By alternating the phosphorylation states of α− and β- tubulin in microtubules using phospho-mimetic mutants, a “toggle switch” model will be explored as a novel decision point that governs cancer-related phenotypes. This model will be rigorously tested by co-expression of site-directed mutants of α-tubulin (S165D or control S165N) and β-tubulin (S172D or control S172N) in human breast cells. By use of these constructs, proliferation and motility as well as EMT markers (E- vs. N-cadherin) will be evaluated. Molecular dynamics simulations will be used to screen the alignment of α:Glu254 with β:GTP both in the α/β-tubulin mutant constructs and in those mutants to be identified in tumor genomic databases; their significance will be verified experimentally by the presence of GTP caps and cell phenotypes (proliferation, motility). In vivo support for the α/β-tubulin toggle switch will be sought in an orthotopic animal model with highly aggressive breast cells to evaluate: 1) the impact of phospho-mimetic mutant constructs of α/β-tubulin, and 2) the efficacy of small molecule inhibitors of PKC and cdk1. The purpose of these studies is to establish a novel framework for assessing metastatic potential and to explore improved strategies for breast cancer chemotherapy.
HHS’ Tracking Accountability in Government Grants System (TAGGS) website provides access to detailed descriptions of grants, loans, aggregated direct payments and other types of financial assistance awarded by the HHS Operating Divisions (OPDIVs) and the Office of the Secretary Staff Divisions (STAFFDIVs).